CGS vs MVP

ASX Healthcare sector comparison — updated 3 Sep 2026 — Healthcare sector

CGS

COGSTATE FPO [CGS]

57MEDIUM

MVP

MEDICALDEV FPO [MVP]

62MEDIUM-HIGH

Score Breakdown

CGS MVP
Technical
61
68
Catalyst
55
50
Sentiment
50
50
Fundamental
99
95
Momentum
64
51
Risk Gate
45
50

Key Metrics

CGS Metric MVP
$523.4MMarket Cap$52.9M
699KAvg Volume (20d)214K
+0.0%Short InterestN/A
$3.23052-Week High$0.765
$1.69052-Week Low$0.365
-0.3%Daily Change+2.2%
$3.070Reference Price$0.460
+22.5%ROE+1.1%
+19.5%Profit Margin+1.5%

Active Signals

CGS Signals

●Beating the Small Ords index — relative strength of 1.21, so it's outpacing the pack
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Moderate P/S ratio (8.6x)
●Moderate revenue growth (+16%)
●Piotroski F-Score strong (8/9, low-confidence approx)
●EPS estimates revised upward (+10pts)
●Near 52-week high (90% of range)

MVP Signals

●Stochastic is deep in oversold territory — bounce conditions forming
●Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Low P/S ratio (1.2x)
●Moderate revenue growth (+10%)
●Piotroski F-Score strong (8/9, low-confidence approx)
●EPS estimates revised upward (+10pts)

Ask Scout AI to compare CGS and MVP in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

EYE vs IMM →AHC vs EYE →AHC vs ATH →ARX vs MVP →ATX vs CUV →
CGS Full Analysis → MVP Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).